Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4326432

O=C(N[C@H]1C[C@@H]1c1ccccc1)c1nc(-c2cccc(Cl)c2)c2ccccn12.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ATM Q13315 4/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
RORC P51449 11/20 0.42
PPARG P37231 2/20 0.41
EPHX2 P34913 1/20 0.40
CSNK1E P49674 1/20 0.38
DYRK1A Q13627 2/20 0.38
CLK2 P49760 1/20 0.38
CLK3 P49761 1/20 0.38
WNT1 P04628 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13578172 0.95 RORC (0.43) RORCPPARGEPHX2CSNK1EDYRK1A
Trifluoroacetic Acid SCHEMBL4325196 0.86 RORC (0.43) RORCPPARGDYRK1ACLK2CLK3
Trifluoroacetic Acid SCHEMBL4318631 0.84 ATM (0.45) CASP3SENP8SENP7SENP6L3MBTL1
Trifluoroacetic Acid SCHEMBL4325301 0.83 CNR2 (0.51) CASP3SENP8SENP7SENP6L3MBTL1
Trifluoroacetic Acid SCHEMBL4329769 0.82 ATM (0.44) CASP3SENP8SENP7SENP6L3MBTL1
Trifluoroacetic Acid SCHEMBL4341502 0.81 CNR2 (0.48) CASP3SENP8SENP7SENP6L3MBTL1
Trifluoroacetic Acid SCHEMBL4333038 0.81 KMT2A (0.48) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL13578193 0.81 PPARG (0.44) RORCPPARGEPHX2
Trifluoroacetic Acid SCHEMBL4322823 0.80 MAPK1 (0.46) CASP3SENP8SENP7SENP6L3MBTL1
Trifluoroacetic Acid SCHEMBL4333549 0.78 ATM (0.42) CASP3SENP8SENP7SENP6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325936-A1 IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES MERCK & CO., INC. 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325936-A1 IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES CNR2, CNR1, TRPV1 CASP3 3788/4885SENP8 4342/4885SENP7 4168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.